Related Experiment Videos
[Raynaud's phenomenon and connective tissue diseases]
J L Guilmot1, E Diot, G Lasfargues
1Service de médecine interne B, CHU Bretonneau, Tours.
La Revue Du Praticien
|November 14, 1998
Summary
Connective tissue diseases, particularly systemic sclerosis, are key causes of Raynaud
Area of Science:
- Rheumatology and Immunology
- Vascular Biology and Medicine
Context:
- Raynaud's phenomenon is frequently associated with connective tissue diseases.
- Systemic sclerosis represents the most common underlying cause.
- Accurate diagnosis relies on detailed patient history, clinical evaluation, capillaroscopy, and autoantibody testing.
Purpose:
- To review the diagnostic approaches for Raynaud's phenomenon.
- To highlight the role of connective tissue diseases in its etiology.
- To discuss recent advancements in understanding blood flow regulation and potential therapeutic targets.
Summary:
- Connective tissue diseases are primary organic causes of Raynaud's phenomenon, with systemic sclerosis being the most prevalent.
- Diagnostic accuracy is enhanced by capillaroscopy and specific autoantibody tests following thorough clinical assessment.
- Advances in understanding neuromediators and endothelial-derived substances offer new therapeutic avenues for this challenging condition.
Impact:
- Improved diagnostic strategies for Raynaud's phenomenon.
- Potential for novel therapeutic interventions targeting local blood flow regulation.
- Enhanced understanding of the link between systemic sclerosis and vascular dysfunction.